This document discusses renal failure and acute kidney injury (AKI). It defines AKI and outlines its causes, which include prerenal, intrinsic renal, and postrenal factors. The main types of intrinsic renal injury are acute tubular necrosis, glomerulonephritis, and interstitial nephritis. Signs and symptoms of AKI include oliguria, edema, and flank pain. The document also describes methods of diagnosing and classifying the severity of AKI.
Gastritis is a condition in which the stomach
lining—known as the mucosa—is inflamed. The stomach lining contains special
cells that produce acid and enzymes, which help break down food for digestion,
and mucus, which protects the stomach lining from acid. When the stomach lining
is inflamed, it produces less acid, enzymes, and mucus.
Gastritis may be acute or chronic. Sudden,
severe inflammation of the stomach lining is called acute gastritis. Inflammation
that lasts for a long time is called chronic gastritis. If chronic gastritis is
not treated, it may last for years or even a lifetime.
Erosive gastritis is a type of gastritis that
often does not cause significant inflammation but can wear away the stomach
lining. Erosive gastritis can cause bleeding, erosions, or ulcers. Erosive
gastritis may be acute or chronic.
The relationship between gastritis and
symptoms is not clear. The term gastritis refers specifically to abnormal
inflammation in the stomach lining. People who have gastritis may experience
pain or discomfort in the upper abdomen, but many people with gastritis do not
have any symptoms.
The term gastritis is sometimes mistakenly
used to describe any symptoms of pain or discomfort in the upper abdomen. Many
diseases and disorders can cause these symptoms. Most people who have upper
abdominal symptoms do not have gastritis.
Gastritis is a condition in which the stomach
lining—known as the mucosa—is inflamed. The stomach lining contains special
cells that produce acid and enzymes, which help break down food for digestion,
and mucus, which protects the stomach lining from acid. When the stomach lining
is inflamed, it produces less acid, enzymes, and mucus.
Gastritis may be acute or chronic. Sudden,
severe inflammation of the stomach lining is called acute gastritis. Inflammation
that lasts for a long time is called chronic gastritis. If chronic gastritis is
not treated, it may last for years or even a lifetime.
Erosive gastritis is a type of gastritis that
often does not cause significant inflammation but can wear away the stomach
lining. Erosive gastritis can cause bleeding, erosions, or ulcers. Erosive
gastritis may be acute or chronic.
The relationship between gastritis and
symptoms is not clear. The term gastritis refers specifically to abnormal
inflammation in the stomach lining. People who have gastritis may experience
pain or discomfort in the upper abdomen, but many people with gastritis do not
have any symptoms.
The term gastritis is sometimes mistakenly
used to describe any symptoms of pain or discomfort in the upper abdomen. Many
diseases and disorders can cause these symptoms. Most people who have upper
abdominal symptoms do not have gastritis.
basics about chronic liver disease for a pediatrician. fast and easy guide to common causes of chronic liver diseases in children
Please leave a comment if you like it..
basics about chronic liver disease for a pediatrician. fast and easy guide to common causes of chronic liver diseases in children
Please leave a comment if you like it..
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
2. Contents:
Functional Anatomy and
Physiology of Kidney
Pathophysiology
Types
Causes
Sign and Symptoms
Differential Diagnosis
Investigations and Findings
Treatment
Complications if not treated
Reference
WorldKidneyDay12thMarch.
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 2
5. Types :
Acute Renal Failure
(ARF) OR
Acute Kidney Injury
(AKI)
Chronic Renal Failure
(CRF) OR
Chronic Kidney Disease
(CKD)
Renal Failure
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 5
6. AKI Background:
Acute kidney injury (AKI), previously referred to as acute renal Failure
It describes the situation where there is a sudden and often reversible
loss of renal function Which develops over days or weeks accompanied by
a reduction in urine volume.
It is important to recognize that AKI is a clinical diagnosis and not a
structural one.
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 6
7. AKI Background: …
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 7
Using consensus criteria, an estimated 20% of hospitalized
patients develop AKI, and nearly 60% of intensive care unit
patients incur AKI
Greater than 40% of hospital-associated AKI is iatrogenic
Most common cause of AKI in hospitalized patients is intrinsic
kidney failure caused by acute tubular necrosis (ATN) and prerenal
disease
8. AKI Causes :
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 8
• Prerenal: inadequate renal perfusion caused by hypovolemia,
congestive heart failure (impaired cardiac output), cirrhosis (fluid
third-spacing), sepsis (vasodilation), abdominal compartment
syndrome, or other. Sixty percent of community-acquired cases of
AKI are from prerenal conditions.
• Postrenal: bladder outlet obstruction (prostatic
enlargement, urethral fibrosis), ureteral obstruction (stones, bladder
masses, retroperitoneal fibrosis, ureteral fibrosis), or renal vein
occlusion. With two functioning kidneys, bilateral obstruction is
usually required to cause significant AKI. Postrenal causes of AKI
account for 5% to 15% of community acquired AKI.
• Intrinsic renal: ATN, glomerulonephritis, AIN. Common causes of
ATN include ischemia (e.g., hypotension or shock, post cardiac bypass
or aorta surgery), rhabdomyolysis, sepsis, drug toxicity (e.g.,
aminoglycosides, amphotericin, cisplatin), and iodinated radiocontrast
nephropathy. Contrast-induced nephropathy is the third-most common
cause of new-onset AKI in hospitalized patients. AIN can develop after
exposure to a variety of medications, most commonly nonsteroidal
anti-inflammatory drugs, antibiotics, and proton pump inhibitors
Poisonous Mushroom ,Heavy
Metals and Semicarpus Causes
ATN.
9. AKI Types :
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 9
Prerenal ARF
Intrinsic renal ARF
Postrenal ARF.
11. AKI Renal Causes :
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 11
Causes of intrinsic renal ARF
−− Renal artery obstruction by
atherosclerotic, plaque,
thrombosis, embolism, vasculitis.
−− Renal vein obstruction by
thrombosis/compression.
−− Disease of the glomeruli and renal
micro- vasculature:
–– Glomerulonephritis and vasculitis.
–– Secondary diseases
—Hemolytic uremic syndrome (HUS),
(DIC), Systemic lupus erythematosus
Progressive systemic sclerosis (PSS),
toxemia of pregnancy and malignant HTN.
−− Causes of acute tubular necrosis
(ATN)
–– Ischemic causes of ATN—Causes are
same as prerenal ARF.
Due to vasoconstriction of efferent arteriole
in severe hypovolemia leads to severe
decrease in blood supply to tubular cells.
12. AKI Renal Causes : …
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 12
Nephrotoxic substance causing ATN
»» Exogenous—Radiocontrast dye,
aminoglycoside,
paracetamol, solvent like ethylene
glycol,
cyclosporine and cisplatin.
»» Endogenous—Myoglobin,
hemoglobin, uric
acid, oxalate and myeloma protein.
−− Interstitial nephritis—Responsible
for ATN
–– Allergic causes:
»» β-lactam and sulfonamide
»» Trimethoprim and rifampicin
»» NSAID and captopril.
–– Infections:
»» Pyelonephritis
»» Leptospirosis
»» CMV
»» Candida.
–– Idiopathic
–– Infiltration:
»» Lymphoma
»» Leukemia
»» Sarcoidosis.
−− Renal allograft rejection.
13. AKI Postrenal Causes :
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 13
Postrenal:
Bladder outlet obstruction (prostatic enlargement, urethral fibrosis)
Ureteral obstruction (stones, bladder masses, retroperitoneal
fibrosis, ureteral fibrosis), or renal vein occlusion.
With two functioning kidneys, bilateral obstruction is usually required to
cause significant AKI.
Postrenal causes of AKI account for 5% to 15% of community acquired AKI.
15. AKI Stages: …
The acronym RIFLE is used to define the spectrum of progressive Kiney Injury in
AKI.
Risk: 1.5 fold increase in serum creatinine or GFR decrease by 25% for 6 hours.
Injury: 2 fold increase in serum creatinine or GFR decrease by 50% for 12 hours.
Failure: 3 fold increase in serum creatinine or GFR decrease by 75% for 24 hours
or no urine output for 12 hours.
Loss: Complete loss of Kidney Function ( eg. Need for Renal Replacement
Therapy) for more than 4 weeks.
End-Stage Kidney Disease: Complete loss of Kidney Function ( eg. Need for Renal
Replacement Therapy ) for more than 3 months.
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 15
16. AKI Sign & Symptoms:
Symptoms
Oliguria (urine output < 500 mL/day). But oliguria may not be always present.
Increase thirst
Orthostatic dizziness and hypotension
Tachycardia
Decreased skin turgor
Dry mucous membrane
Reduced sweating in axilla
Reduced jugular venous pressure.
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 16
17. AKI Sign & Symptoms: …
Signs
Flank pain is due to:
− Renal artery/vein occlusion.
− AGN produce pain by distending
the renal capsule.
Pyelonephritis and obstructive
uropathy can produce -- pain.
Digital ischemia—Indicates
atheroembolism as a cause for ARF.
ARF with oliguria, hypertension,
edema and active urinary sediment
indicate AGN or vasculitis.
Very high BP in malignant HTN can
cause ARF which is associated with
LVH/LVF/papilledema/neurologic
dysfunction.
Fever, arthralgia and pruritus following
some drugs may cause allergic
interstitial nephritis.
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 17
18. AKI Sign & Symptoms: …
SPECIAL POINTS OF POSTRENAL ARF
Suprapubic and flank pain is a feature
of distention of bladder or renal pelvis
and capsule.
Colicky pain radiating to groin suggests
ureteric colic due to obstruction.
Prostatic disease is suggested by
nocturia, frequency, hesitancy, difficulty
in initiation, narrow stream and
confirmed by rectal examination of
prostate or USG of kidney ureter
bladder prostate (KUBP).
Neurogenic bladder is caused by
anticholinergic drugs, autonomic
dysfunction and paraplegia due to
spinal cord injury
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 18
19. AKI Differential Diagnosis :
Causes of AKI Some Clinical Features Typical Urinalysis
Result
Confirmatory Tests
Diseases
Involving Large
Renal Vessels:
Renal artery
thrombosis
History of atrial fibrillation or recent
myocardial infarction, nausea, vomiting,
flank or abdominal pain
Mild proteinuria
Occasionally RBCs
Elevated LDH level
with normal
transaminase
levels, renal
arteriogram
Atheroembolism Usually age > 50 yr, recent manipulation
of aorta, retinal plaques, subcutaneous
nodules, palpable purpura, livedo
reticularis
Often normal
Eosinophiluria
Rarely casts
Eosinophilia,
hypocomplementem
ia, skin
biopsy, renal biopsy
Renal vein
thrombosis
Evidence of nephrotic syndrome or
pulmonary
embolism, flank pain
Proteinuria,
hematuria
Inferior
venacavogram,
Doppler flow
studies, MRV*
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 19
20. AKI Differential Diagnosis : …
Causes of AKI Some Clinical Features Typical
Urinalysis
Result
Confirmatory
Tests
Prerenal azotemia Evidence of true volume depletion
(thirst, postural or absolute
hypotension and tachycardia, low
jugular venous pressure, dry mucous
membranes and axillae, weight loss,
fluid output greater than input) or
decreased effective circulatory
volume (e.g., heart failure, liver failure),
treatment with NSAID, diuretic, or ACE
inhibitor/ARB
Hyaline casts
SG > 1.018
Occasionally
requires invasive
hemodynamic
monitoring; rapid
resolution of
AKI with
restoration of renal
perfusion
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 20
21. AKI Differential Diagnosis : …
Causes of AKI Some Clinical Features Typical Urinalysis
Result
Confirmatory Tests
Diseases of
Small Renal
Vessels and
Glomeruli:
Glomerulonephri
tis or vasculitis
Compatible clinical history
(e.g., recent
infection), sinusitis, lung
hemorrhage, rash or skin
ulcers, arthralgia's,
hypertension, edema
RBC or granular
casts, RBCs, white
blood cells,
proteinuria
Low complement levels; positive
antineutrophil cytoplasmic antibodies,
anti–glomerular basement membrane
antibodies, anti–streptolysin O
antibodies, anti-DNase, cryoglobulins;
renal biopsy
HUS/TTP Compatible clinical history
(e.g., recent
gastrointestinal infection,
cyclosporine, anovulants),
pallor, ecchymoses,
neurologic Findings
May be normal,
RBCs, mild
proteinuria,
rarely RBC or
granular casts
Anemia, thrombocytopenia,
schistocytes
on peripheral blood smear, low
haptoglobin level, increased LDH,
renal biopsy
Malignant
hypertension
Severe hypertension with
headaches, cardiac failure,
retinopathy, neurologic
dysfunction, papilledema
May be normal,
RBCs, mild
proteinuria,
rarely RBC casts
LVH by echocardiography or ECG,
resolution of AKI with BP control
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 21
22. AKI Differential Diagnosis : …
Causes of AKI Some Clinical Features Typical
Urinalysis Result
Confirmatory Tests
Ischemic or
Nephrotoxic Acute
Tubular Necrosis:
Ischemia
Recent hemorrhage, hypotension,
surgery often in combination with
vasoactive medication (e.g., ACE
inhibitor, NSAID)
Muddy-brown
granular or tubular
epithelial cell casts
SG ≈ 1.010
Clinical assessment and urinalysis
usually inform diagnosis
Exogenous toxin Recent contrast medium–
enhanced procedure; nephrotoxic
medications; certain
chemotherapeutic agents often
with coexistent volume depletion,
sepsis, or chronic kidney disease
Muddy-brown
granular or tubular
epithelial cell casts
SG ≈ 1.010
Clinical assessment and urinalysis
usually inform diagnosis
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 22
23. AKI Differential Diagnosis : …
Causes of
AKI
Some Clinical
Features
Typical Urinalysis Result Confirmatory Tests
Endogeno
us toxin
History suggestive of
rhabdomyolysis
(coma, seizures,
drug abuse, trauma)
History suggestive of
hemolysis (recent
blood transfusion)
History suggestive of
tumor lysis (recent
chemotherapy),
myeloma (bone
pain), or ethylene
glycol ingestion
Urine supernatant tests
positive for heme in
absence of RBCs
Urine supernatant pink
and tests positive for
heme in absence of RBCs
Urate crystals, dipstick-
negative proteinuria,
oxalate crystals,
Respectively
Hyperkalemia, hyperphosphatemia,
hypocalcemia, increased CK,
Myoglobin
Hyperkalemia, hyperphosphatemia,
hypocalcemia, hyperuricemia, and
free circulating hemoglobin
Hyperuricemia, hyperkalemia,
hyperphosphatemia (for tumor
lysis); circulating or urinary
monoclonal protein (for myeloma);
toxicology screen, acidosis, osmolal
gap (for ethylene glycol)
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 23
24. AKI Differential Diagnosis : …
Causes of AKI Some Clinical
Features
Typical Urinalysis Result Confirmatory Tests
Diseases of
the
Tubulointerst
itium:
Allergic
interstitial
nephritis
Recent ingestion
of drug and fever,
rash, loin pain, or
arthralgia's
White blood cell casts, white
blood cells (frequently
eosinophiluria), RBCs, rarely
RBC casts, proteinuria
(occasionally nephritic)
Systemic eosinophilia, renal biopsy
Acute bilateral
pyelonephritis
Fever, flank pain
and tenderness,
toxic State
Leukocytes, occasionally
white blood cell casts, RBCs,
bacteria
Urine and blood cultures
Postrenal AKI Abdominal and
flank pain,
palpable bladder
Frequently normal,
hematuria if
stones, prostatic
hypertrophy
Plain abdominal radiography, renal
ultrasonography, post void residual
bladder volume, computed
tomography, retrograde or antegradeRenal Failure; Dr Hari Sharan Aryal; 2076.11.29 24
25. AKI Investigations : …
LABORATORY TESTS
• Elevated serum creatinine: rate of rise is
approximately 0.5 to 2 mg/dl/day in
complete kidney failure.
• Elevated blood urea nitrogen (BUN): BUN
to- creatinine ratio is commonly >20:1 in
prerenal azotemia, Postrenal azotemia, and
acute glomerulonephritis.
• BUN-to-creatinine ratio is <20:1 in acute
interstitial nephritis and ATN.
• Hyperkalemia, hyperphosphatemia, and
metabolic acidosis are common.
• Hypocalcemia and hyponatremia or
hypernatremia may occur, depending on
underlying etiology.
• Complete blood count may reveal anemia
from decreased erythropoietin production.
• Urinalysis is the initial step of diagnostic
evaluation. Prerenal and Postrenal AKI are
typically characterized by a normal
urinalysis.
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 25
26. AKI Investigations : ...
IMAGING STUDIES
• ECG for arrhythmia detection, especially
in hyperkalemia: peaked T waves in
precordial leads, widening QRS interval,
and/or bradycardia with AV nodal blockade
• Chest radiograph to detect signs of
congestive heart failure and pulmonary
renal syndromes often characterized by
pulmonary alveolar hemorrhage.
• Kidney ultrasonography to determine
kidney sizes (distinguishes acute from
chronic kidney disease), presence of
obstruction, and renal vascular status
(Doppler study)
• Computed tomography (CT) with
radiocontrast administration is typically
avoided in AKI. However, unenhanced CT
scans may identify obstructing ureteral
stones.
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 26
27. AKI Treatment :
TREATMENT OF COMPLICATIONS of ACUTE
RENAL FAILURE:
• Volume overload is managed by:
− Salt restricted to 1–2 gm/day.
− Water intake <500 mL + previous 24 hours
urine output.
− Diuretic—Frusemide and thiazide
− Ultrafiltration and dialysis.
• Hyponatremia is managed by:
− Restriction of water <1 L/day.
− Avoid IV hypotonic solution like dextrose In
severe hyponatremia.
− 3% hypertonic saline infusion.
• Hyperkalemia is managed by:
− Restrict dietary potassium <40 mmol/day.
− Eliminate potassium supplement and
potassium sparing diuretic, fruit and fruit
juice, ACEI/ARB.
− Calcium gluconate or calcium chloride
(10%) 10 mL over 10 minutes (emergency
treatment).
− Slow IV infusion of 50 mL 50% dextrose
with 12 U regular insulin.
− Sodium bicarbonate—50–100 mmol IV
infusion if ARF is associated with acidosis.
− Dialysis or hemofiltration.
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 27
28. AKI Treatment : …
TREATMENT OF COMPLICATIONS of ACUTE:
•Metabolic acidosis is managed by:
− Restrict dietary protein to 0.5 gm/kg/day.
− Inj. Na bicarbonate (50–100 mmol IV) to
maintain pH >7.2 and bicarbonate >15 mmol/L.
Na-bicarbonate 500 mg tds orally.
− Dialysis.
• Hyperphosphatemia is managed by:
− Restrict dietary phosphate <800 mg/day.
− Phosphate binding
• Hypocalcemia is managed by:
− CaCO3—1000–1500 mg/day orally.
• Hypermagnesemia is managed by:
− Discontinue Mg containing antacids.
• Hyperuricemia is managed:
− Usually no treatment is necessary if serum
uric acid <7.0 mg/dL.
− Allopurinal of— 200 mg/day
− Febuxostat 40 to 80 mg/day.
• Nutrition is managed by:
− Restrict dietary protein <0.5 g/kg/day.
− Carbohydrate 100 g/day.
− Enteral/parenteral nutrition.
• Anemia is treated by:
− Packed cell transfusion and injection
erythropoietin by subcutaneous route. 4000 K
on alternate day.
• Renal replacement therapy.
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 28
29. Indication For Dialysis :
• Diuretic resistance—Severe
hypervolemia causing CCF and
pulmonary edema.
• Acidosis—pH <7.2.
• Hyperkalemia—K+ level >7 mcg/L.
• Blood urea >200 mg/dL.
• Plasma creatinine >10 mg/dL.
• Pericardial rub.
• Uremic encephalopathy.
− Dialysis in ARF is initiated earlier
particularly in oliguric and critically ill
patient.
− Stable patient with ARF is expected to
recover renal functions within several days
and may benefit from fluid restriction,
restriction of protein, Na+, K+ and PO4
• Inspite of best treatment, mortality rate is
approximately 60%. Bad prognostic
indicators are:
• Older age group
• Multiorgan failure
• Severe oliguria/anuria at presentation
• High plasma creatinine at presentation
• Cachexia.
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 29
31. CKD Background:
Chronic renal failure (CRF) is a syndrome characterized by gradual suppression of
Glomerular filtration rate (GFR) over weeks to months leading to accumulation of
nitrogenous waste product in the body.
Chronic kidney disease (CKD) is diagnosed when there is evidence for more than 3
months of kidney damage (urine albumin >30 mg/g creatinine, hematuria, or
parenchymal abnormalities) and/or decreased kidney function (glomerular filtration
rate, GFR <60 ml/min/1.73 m2).
CKD is characterized by accumulation of metabolic waste products in blood,
electrolyte abnormalities, mineral and bone disorders, and anemia.
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 31
32. CKD Background: …
Chronic Renal Disease : It is a pathophysiologic process of multiple etiology resulting in
irreversible loss of number and function of nephrons frequently leading to end-stage renal
disease (ESRD).
End-stage Renal Disease : It is a clinical stage of chronic renal disease due to irreversible
loss of renal function to a degree sufficient to render the patient dependent on renal
replacement therapy (dialysis or transplant).
Azotemia : Retention of nitrogenous waste products when renal insufficiency develops.
Uremia : This is a clinical and laboratory syndrome that reflects dysfunction of all organs
due to accumulation of nitrogenous waste product as a result of untreated or undertreated
acute or chronic renal failure.
Renal Failure; Dr Hari Sharan Aryal; 2076.11.29 32